Lazard Asset Management
RCEL icon

Lazard Asset Management’s Avita Medical RCEL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$15K Buy
+2,973
New +$15K ﹤0.01% 2142
2025
Q1
Sell
-1,142
Closed -$14K 2530
2024
Q4
$14K Buy
1,142
+1,014
+792% +$12.4K ﹤0.01% 2091
2024
Q3
$1K Buy
+128
New +$1K ﹤0.01% 2197
2024
Q2
Sell
-5,428
Closed -$87K 2393
2024
Q1
$87K Sell
5,428
-388
-7% -$6.22K ﹤0.01% 1582
2023
Q4
$79K Buy
5,816
+406
+8% +$5.52K ﹤0.01% 1755
2023
Q3
$79K Hold
5,410
﹤0.01% 1710
2023
Q2
$92K Buy
5,410
+2,643
+96% +$44.9K ﹤0.01% 1610
2023
Q1
$38K Buy
+2,767
New +$38K ﹤0.01% 1874
2021
Q4
Sell
-3,724
Closed -$65K 2427
2021
Q3
$65K Buy
+3,724
New +$65K ﹤0.01% 1567